Search form
Search
contact us
Navigation
home
boards
job center
job ratings
cp wire
device news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
» Taltz
Taltz
Novartis takes aim at Eli Lilly with Cosentyx FDA nod in spondyloarthritis
Novartis takes aim at Eli Lilly with Cosentyx FDA nod in spondyloarthritis
Fierce Pharma
Novartis
Eli Lilly
Cosentyx
Taltz
spondyloarthritis
Flag link:
Eli Lilly's Taltz beats Novartis to the punch with FDA approval in spondyloarthritis
Eli Lilly's Taltz beats Novartis to the punch with FDA approval in spondyloarthritis
Fierce Pharma
Eli Lilly
Taltz
Novartis
Cosentyx
axial spondyloarthritis
Flag link:
Eli Lilly's Taltz extends its head-to-head Humira beat with 52-week psoriatic arthritis data
Eli Lilly's Taltz extends its head-to-head Humira beat with 52-week psoriatic arthritis data
Fierce Pharma
Eli Lilly
Taltz
psoriatic arthritis
AbbVie
Humira
Flag link:
Lilly counts on growing markets to boost lagging Taltz, Trulicity
Lilly counts on growing markets to boost lagging Taltz, Trulicity
Fierce Pharma
Eli Lilly
Trulicity
Taltz
immunology
type 2 diabetes
Flag link:
Lilly's Taltz wins third approval, this time in patients with active ankylosing spondylitis
Lilly's Taltz wins third approval, this time in patients with active ankylosing spondylitis
Endpoints
Eli Lilly
monoclonal antibodies
Taltz
ankylosing spondylitis
FDA
Flag link:
Eli Lilly's Taltz bests J&J rival Tremfya in head-to-head psoriasis tilt
Eli Lilly's Taltz bests J&J rival Tremfya in head-to-head psoriasis tilt
Fierce Pharma
Eli Lilly
Taltz
JNJ
Tremfya
psoriasis
Flag link:
Lilly’s Taltz scrapes win against Humira in psoriatic arthritis
Lilly’s Taltz scrapes win against Humira in psoriatic arthritis
Pharmaforum
Eli Lilly
Taltz
AbbVie
Humira
psoriatic arthritis
Flag link:
Eli Lilly's Taltz touts long-term clear skin data after unimpressive first-quarter sales
Eli Lilly's Taltz touts long-term clear skin data after unimpressive first-quarter sales
Fierce Pharma
Eli Lilly
Taltz
psoriasis
Flag link:
Eli Lilly Falls Despite Positive Phase 3 Results From Taltz Study
Eli Lilly Falls Despite Positive Phase 3 Results From Taltz Study
TheStreet.com
Eli Lilly
axial spondyloarthritis
clinical trials
Taltz
Flag link:
Johnson & Johnson keeps the heat on Tremfya's rivals with at-home injector nod
Johnson & Johnson keeps the heat on Tremfya's rivals with at-home injector nod
Fierce Pharma
JNJ
Janssen
Tremfya
psoriasis
Novartis
Cosentyx
Eli Lilly
Taltz
Flag link:
Lilly says Taltz superior to Humira in late-stage psoriatic arthritis trial
Lilly says Taltz superior to Humira in late-stage psoriatic arthritis trial
Reuters
Eli Lilly
psoriatic arthritis
Taltz
AbbVie
Humira
clinical trials
Flag link:
Eli Lilly Updates Spondyloarthritis Trial Data and Long-Term Rheumatoid Arthritis Studies
Eli Lilly Updates Spondyloarthritis Trial Data and Long-Term Rheumatoid Arthritis Studies
BioSpace
Eli Lilly
Taltz
asxSpA
Flag link:
Touting PhIII success for arthritis drug Taltz, Eli Lilly chases rival Novartis in heated immunology race
Touting PhIII success for arthritis drug Taltz, Eli Lilly chases rival Novartis in heated immunology race
Endpoints
Eli Lilly
Taltz
Novartis
ankylosing spondylitis
Cosentyx
Flag link:
Eli Lilly Builds Case to Expand Immune Drug’s Use to Spinal Arthritis
Eli Lilly Builds Case to Expand Immune Drug’s Use to Spinal Arthritis
Xconomy
Eli Lilly
Taltz
Flag link:
Eli Lilly touts PhIII success for Taltz as rival Novartis stays well out front in crowded immunology race
Eli Lilly touts PhIII success for Taltz as rival Novartis stays well out front in crowded immunology race
Endpoints
Eli Lilly
Taltz
Novartis
ankylosing spondylitis
Cosentyx
Flag link:
Lilly's 2018 forecast beats on strength of new drugs
Lilly's 2018 forecast beats on strength of new drugs
Yahoo/Reuters
Eli Lilly
Trulicity
Taltz
Flag link:
Lilly's Taltz takes Cosentyx rivalry into psoriatic arthritis with new FDA nod
Lilly's Taltz takes Cosentyx rivalry into psoriatic arthritis with new FDA nod
Fierce Pharma
Eli Lilly
Taltz
Novartis
Cosentyx
FDA
psoriatic arthritis
Flag link:
Humira may spend most on TV, but Xeljanz, Taltz and Breo notch highest view rates
Humira may spend most on TV, but Xeljanz, Taltz and Breo notch highest view rates
Fierce Pharma
Humira
Xeljanz
Taltz
Breo
drug ads
television ads
DTC ads
Flag link:
Novartis star Cosentyx, facing new rivals, may gain edge as a disease-modifying med
Novartis star Cosentyx, facing new rivals, may gain edge as a disease-modifying med
Fierce Pharma
Novartis
Cosentyx
psoriasis
Eli Lilly
Taltz
Valeant Pharmaceuticals
Siliq
Flag link:
Are DTC ads tipping the balance in psoriasis battle between Lilly’s Taltz and Novartis’ Cosentyx?
Are DTC ads tipping the balance in psoriasis battle between Lilly’s Taltz and Novartis’ Cosentyx?
Fierce Pharma
DTC advertising
psoriasis
Eli Lilly
Novartis
Taltz
Cosentyx
Flag link:
Pages
1
2
next ›
last »